Klebsiella predominance in peripancreatic microbial spectrum is associated with the severity of infected pancreatic necrosis
- PMID: 40597752
- PMCID: PMC12220423
- DOI: 10.1186/s12879-025-11263-0
Klebsiella predominance in peripancreatic microbial spectrum is associated with the severity of infected pancreatic necrosis
Abstract
Background: Infectious pancreatic necrosis (IPN) is associated with the prognosis of acute pancreatitis (AP). The correlation between microbial diversity in the peripancreatic region and AP severity remains unclear. This study investigates whether pathogen profiles in peripancreatic necrosis differ between IPN patients with and without organ failure (OF), using 16 S ribosomal RNA (16 S rRNA) and internal transcribed spacer (ITS) sequencing.
Methods: Patients with acute pancreatitis meeting clinical diagnostic criteria for IPN were prospectively enrolled. These patients were subsequently divided into an OF group and a non-OF group. Peripancreatic necrotic fluid samples were collected via percutaneous drainage and subjected to 16 S rRNA and ITS sequencing.
Results: A total of 28 patients with suspected infected pancreatic necrosis (IPN) were included, with 14 patients in the OF group and 14 in the non-OF group. No significant difference was observed in bacterial alpha diversity between the OF and non-OF groups. However, beta diversity showed significant differences according to Welch's t test (P < 0.001), Adonis analysis (P = 0.037) and Anosim analysis (P = 0.032). The relative abundance of Klebsiella significantly differed between the two groups (2.79% vs. 34.14%, P = 0.0093) and correlated with the length of hospital stay (r = 0.422, P = 0.025).
Conclusion: The peripancreatic microbial profile is associated with the severity of acute pancreatitis, with Klebsiella being the dominant microflora in patients with IPN combined with OF.
Keywords: 16S ribosomal RNA; Acute pancreatitis; Infected pancreatic necrosis; Internal transcribed spacer (ITS).
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study protocol was approved by the Ethics Committee of Jinling Hospital (Nanjing, China; 2021NZKY-014-01). Written informed consent was obtained from all participants. The procedures followed in this study were in accordance with the principles of the Declaration of Helsinki (1964, amended most recently in 2013) of the World Medical Association. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures






Similar articles
-
Prognostic significance of organ failure and infected pancreatic necrosis in acute pancreatitis: An updated systematic review and meta-analysis.J Dig Dis. 2023 Dec;24(12):648-659. doi: 10.1111/1751-2980.13243. Epub 2024 Jan 7. J Dig Dis. 2023. PMID: 38037512
-
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.Cochrane Database Syst Rev. 2003;(4):CD002941. doi: 10.1002/14651858.CD002941. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2006 Oct 18;(4):CD002941. doi: 10.1002/14651858.CD002941.pub2. PMID: 14583957 Updated.
-
Serum C-reactive protein, procalcitonin, and lactate dehydrogenase for the diagnosis of pancreatic necrosis.Cochrane Database Syst Rev. 2017 Apr 21;4(4):CD012645. doi: 10.1002/14651858.CD012645. Cochrane Database Syst Rev. 2017. PMID: 28431197 Free PMC article.
-
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis.Cochrane Database Syst Rev. 2010 May 12;2010(5):CD002941. doi: 10.1002/14651858.CD002941.pub3. Cochrane Database Syst Rev. 2010. PMID: 20464721 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources